Aclarion, Inc. (ACON )

Currency in USD Disclaimer
$0.69 -$0.13 (-15.94%)
Open 03/14/2025
$0.65
$0.77
$0.65
$231.15

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol ACON
  • Company Aclarion, Inc.
  • Price $0.69
  • Changes Percentage -15.94
  • Change -0.1299
  • Day Low $0.65
  • Day High $0.77
  • Year High $231.15
  • Year Low $0.65
  • Market Cap $695,882
  • Price Avg 50 EMA (D) $15.59
  • Price Avg 200 EMA (D) $59.96
  • Exchange NASDAQ
  • Volume 3,462,888
  • Average Volume 3,932,428
  • Open $0.75
  • Previous Close $0.81
  • EPS -804.49
  • PE 0.00
  • Earnings Announcement 2025-03-27 04:00:00
  • Shares Outstanding $1,015,886

Company brief: ACLARION, INC. (ACON )

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

ACON Corporation News

Aclarion Provides Shareholder Update

Aclarion Provides Shareholder Update

March 13, 2025 at 1:25 pm ET

globenewswire.com -- BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and p...

Income Statement